Company Turda Pharm Srl with Fiscal Code 34079247
recorded a turnover of 2024 of
449.131,
with a net profit of
142.682
and having an average number of employees of
2.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Turda Pharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
0
143.565
151.212
223.218
339.786
452.003
409.724
472.984
406.902
449.131
Total Income - EUR
0
144.420
151.915
223.392
339.840
452.072
410.123
474.405
407.550
449.609
Total Expenses - EUR
982
131.578
118.767
155.468
218.393
286.470
260.135
305.709
294.461
294.936
Gross Profit/Loss - EUR
-982
12.842
33.148
67.925
121.447
165.603
149.987
168.695
113.090
154.673
Net Profit/Loss - EUR
-982
9.400
31.766
65.692
118.049
161.401
146.380
163.957
109.008
142.682
Employees
0
1
1
1
1
1
1
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 11.0%, from 406.902 euro in the year 2023, to 449.131 euro in 2024.
The Net Profit increased by 34.283 euro, from 109.008 euro in 2023, to 142.682 in the last year.
Check the financial reports for the company - Turda Pharm Srl
Financial Rating - TURDA PHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Turda Pharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Turda Pharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Turda Pharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Turda Pharm Srl - CUI 34079247
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
66
0
0
20.268
16.404
11.957
6.865
7.754
4.797
3.248
Current Assets
25.847
101.220
129.707
185.602
278.264
350.825
344.599
484.853
427.981
471.283
Inventories
16.440
27.988
32.535
53.520
64.593
90.813
79.582
197.764
193.612
224.006
Receivables
8.862
71.155
93.565
132.362
211.975
255.319
249.399
286.910
232.972
242.127
Cash
545
2.077
3.606
-279
1.696
4.692
15.618
180
1.397
5.151
Shareholders Funds
-937
8.473
40.096
105.052
141.721
228.841
272.475
271.533
323.024
376.140
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
26.849
92.746
89.610
100.818
152.946
133.941
78.989
221.074
109.754
98.392
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
471.283 euro in 2024 which includes Inventories of
224.006 euro, Receivables of
242.127 euro and cash availability of
5.151 euro.
The company's Equity was valued at
376.140 euro, while total Liabilities amounted to
98.392 euro.
Equity increased by 54.920 euro, from 323.024 euro in 2023, to 376.140 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Turda Pharm Srl